| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 2,588,000 | 2,415,900 | | Cost of Revenue | 1,894,000 | 1,764,200 | | | Gross Profit | 694,000 | 651,700 | | | Operating Expenses | | Research Development | 92,900 | 84,200 | | Selling General and Administrative | 354,600 | 299,800 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 246,500 | 267,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (600) | (32,600) | | Earnings Before Interest And Taxes | 251,500 | 241,200 | | Interest Expense |
-
| 4,500 | | Income Before Tax | 251,500 | 236,700 | | Income Tax Expense | 38,200 | 111,300 | | Minority Interest | (2,500) | (3,000) | | | | Net Income From Continuing Ops | 213,300 | 125,400 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 213,300 | 125,400 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $213,300 | $125,400 |
|
1.52% Nasdaq 0.00%
Income Statement
